**Core tip:** Dysbiosis in pouchitis might be similar to that observed in ulcerative colitis (UC). This study aimed to determine the altered microflora in patients with UC and pouchitis, and to investigate the relationship between them. We demonstrated the reduced biodiversity of the fecal microbiota in UC and pouchitis patients. The altered composition of the intestinal microbiota in UC and pouchitis included decreased numbers of two bacteria commonly observed in UC, and higher levels of *Clostridium perfringens* in both UC and pouchitis. The increase of this bacterium in feces suggested that it plays a role in exacerbating UC and pouchitis.

INTRODUCTION
============

One of the most common complications in ulcerative colitis (UC) patients who undergo ileal pouch-anal anastomosis (IPAA) surgery is pouchitis\[[@B1]\]. Interestingly, it is rarely seen in postoperative patients suffering from familial adenomatous polyposis. The gut microbiome plays a vital role in UC\[[@B2]\]. Antibiotics and probiotics are used to treat and prevent pouchitis\[[@B3]\]. The gut microbiome might play a vital role in the pathogenesis of UC\[[@B4]\].

However, direct evidence of the role of microflora in pathogenesis of pouchitis is lacking. Studies have shown variation in the microbiota in pouchitis and healthy controls; however, based on different culture methods and molecular biology techniques, no consensus was available\[[@B3]\]. Johnson et al\[[@B5]\] and Lim et al\[[@B6]\] showed no differences between pouchitis and no pouchitis (NP) groups. Some studies have suggested a reduction in bacterial diversity in pouchitis but not dysbiosis\[[@B7]\]. Other studies revealed an increase in bacterial diversity in pouchitis\[[@B8]\], such as increased numbers of *Clostridium* and *Eubacterium*\[[@B9]\], while others showed less *Enterococcaceae* in pouchitis\[[@B10]\]. The findings of the most recent study revealed that disorders caused by protective and harmful bacteria are associated with pouch inflammation\[[@B11]\]. The emergence of *Ruminococcus gnavus* (R. *gnavus*), *Bacteriodes vulgatus* and *Clostridium perfringens (C. perfringens*) and deficiency of *Blautia* and *Roseburia* in patients with UC before IPAA is closely related to pouchitis\[[@B12]\].

Denaturing gradient gel electrophoresis (DGGE) was reported to be useful to analyze changes in the composition of the intestinal microbiota\[[@B2]\]. We hypothesized that dysbiosis occurring in the pouch might be similar to that observed in UC. Thus, we determined the altered microflora in pouchitis and UC patients, and investigated the relationship between them.

MATERIALS AND METHODS
=====================

Patients and fecal samples
--------------------------

Patients who underwent IPAA for UC were recruited. Pouchitis was diagnosed based on symptoms, endoscopy and histology of the pouch. Patients underwent pouch endoscopy and biopsy. Physicians recorded clinical data, the pouch appearance and pathological manifestations based on the pouchitis disease activity index (PDAI)\[[@B13]\]. Antibiotic or other drug therapy was stopped to prevent variations in the microbiome 4 wk before collecting the fecal sample. A limited number of patients with pouches were excluded from the study because of antibiotic or probiotic usage for pouchitis or severe concomitant disease.

According to the PDAI, patients with IPAA were divided into two groups: NP, PDAI \< 7 points (*n =* 11) and pouchitis, PDAI ≥ 7 points (*n =* 8). Matched fecal samples were obtained from healthy controls (*n =* 16) and from 41 UC patients who did not undergo IPAA. All the UC patients without a pouch underwent endoscopy. The Mayo scoring system for assessment of ulcerative colitis activity was employed to divide patients with UC into the remission group (*n =* 10), mild activity group (*n =* 11), moderate activity group (*n =* 10) and severe activity group (*n =* 10).

All fecal samples were collected at the hospital and preserved at 4 °C. Upon arrival at the laboratory, the samples were frozen at -80 °C within 12 h. This study was reviewed and approved by the Tianjin Medical University General Hospital Ethical Committee (China). Patient data are summarized in Table [1](#T1){ref-type="table"}.

###### 

Demographic and clinical characteristics of the subjects

                                                  **Healthy controls**   **UC (*n* = 41)**   **Pouch (*n* = 19)**                                            
  ----------------------------------------------- ---------------------- ------------------- ---------------------- ------------ ------------- ------------- -------------
  Number of patients                              16                     10                  11                     10           10            8             11
  Sex, *n*, M/F                                   9/7                    5/5                 7/4                    5/5          6/4           5/3           5/6
  Age (yr)                                        46.2 ± 10.5            41.8 ± 9.2          43.9 ± 10.5            46 ± 8.2     40.8 ± 11.3   44.9 ± 15.6   47.8 ± 13.2
  UC duration (yr)                                NA                     5.0 ± 1.6           7.0 ± 0.9              5.2 ± 1.7    4.0 ± 2.7     NA            NA
  Pouch duration (yr)                             NA                     NA                  NA                     NA           NA            2.8 ± 1.5     3.9 ± 2.2
  BMI (kg/m^2^)                                   24.5 ± 2.3             25.2 ± 1.6          24.8 ± 3.5             23.9 ± 2.7   24.4 ± 3.1    24.9 ± 2.2    24.3 ± 3.5
  Mayo score                                      NA                     ≤ 2                 4.2 ± 0.7              8.5 ± 1.2    11.5 ± 0.3    ≥ 7           \< 7
  Age at colectomy                                NA                     NA                  NA                     NA           NA            40.6 ± 12.9   42.4 ± 9.22
  Standard medication (%)                         NA                     0 (0)               5 (46.0)               8 (80.0)     10 (100)      8 (100)       3 (27.0)
  Smoking (% at recruitment)                      10 (62.5)              4 (40.0)            3 (27.3)               2 (20.0)     3 (30.0)      4 (50.0)      5 (45.5)
  Previous number of episodes of pouchitis (%)    NA                     NA                  NA                     NA           NA            4 (50.0)      3 (27.0)
  Number of patients with chronic pouchitis (%)   NA                     NA                  NA                     NA           NA            3 (37.5)      2 (18.0)
  Secondary causes of pouchitis (%)               NA                     NA                  NA                     NA           NA            2 (25.0)      2 (19.0)

UC: Ulcerative colitis; NA: Not available; Pouch: Ileal pouch established during ileal pouch-anal anastomosis surgery; pouchitis: Inflammation of ileal pouch.

Fecal DNA extraction
--------------------

A Fecal DNA kit (Aidlab Biotechnologies Co, Ltd, Beijing, China) was used to isolate DNA from frozen feces individually, following the manufacturer's guidelines and as previously described\[[@B14]\]. Following 1% agarose gel electrophoresis, the eluted DNA was quantified on a NanoDrop 2000 Spectrophotometer.

PCR amplification
-----------------

The genomic DNA and universal primers including forward and reverse primers (AuGCT DNA technologies, Beijing, China) were employed to amplify the whole fragment V3 region of bacterial 16S rRNA gene.

After 15 cycles of thermocycling on a PCR system (Bio-Rad, Hercules, CA, United States) the amplified product was verified by 2% agarose electrophoresis. The amplified DNA was quantified on a NanoDrop 2000 Spectrophotometer, and recorded by a DH2000 gel imaging analysis.

DGGE for amplified 16S rRNA gene
--------------------------------

DGGE was chosen to separate PCR amplicons according to the rules of Muyzer et al\[[@B15]\], with some modifications. A 10% polyacrylamide combined with Tris-acetate-EDTA (TAE) buffer was used for polyacrylamide gels with a denaturing gradient ranging from 30% to 70%. A stacking gel was added before polymerization of the denaturing gel, followed by appropriate comb insertion. Electrophoresis was performed at 200 V for 5 min and 85 V for 16 h in 0.5 × TAE buffer subsequently at a constant 60 °C. After staining with AgNO~3~\[[@B16]\], the gels were desiccated overnight at 60 °C.

Digital processing of DGGE profiles
-----------------------------------

Following the manufacturer's instructions, DGGE profiles were analyzed digitally using Quantity One-4.6.5 in the UNIVERSAL HOODII Gel Imaging System (Beijing, China). After normalizing the gels according to the results for the healthy controls, the band in each sample was marked by the software, and manual corrections were conducted. The number of DGGE bands was shown as the mean ± SD. Based on the gray value, Dice similarity and UPGMA tree analyses were conducted using Quantity One software. Canoco software was used to conduct principal component analysis (PCA).

DGGE band extraction and sequencing
-----------------------------------

Based on the digital results, the bands distinguishing the groups were excised from the gel, purified and sequenced. The gel slice, in 15 μL of TE buffer, was heated at 65 °C for 10 min to elute the DNA from the gel. The DNA solution was amplified using the universal V3 primers F357+ a GC clamp and R518. DGGE gel expansion facilitated the purification of the bands. DGGE with an adjusted gradient of 32 was used to check the amplicons, which were excised at least three times until a single band was obtained. The DGGE was repeated to purify the PCR product before sequencing. In the final round, the amplicons were analyzed with the original sample profiles from which they were excised and analyzed visually for purification of the correct bands.

When the purified bands matched with the targeted bands, the amplicons sequenced using an ABI Prism system and primers R518 and F357 (without the clamp). BioNumerics software was used to analyze the sequences. BLAST homology searches were performed against the GenBank DNA database. According to BLAST results, the sequences of phylogenetic neighbor species, whose similarities were up to 90%, were included for reference in the cluster analysis using multiple sequence alignments. The purified band sequences were allocated to the most probable species according to the average linking method.

Statistical analysis
--------------------

Quantity One software was used for Dice similarity analysis and UPGMA tree analysis. DGGE strips data are presented as mean ± SD. The Shapiro-Wilk test was used to test the normality of the band number and Dice analysis data. The content of each sample was similar. The homogeneity of variance was robust and highly efficient. The band number of DGGE strips showed a normal distribution, unlike the Dice analysis results. Therefore, the three groups were tested using a Student-Newman-Keuls test. The Bonferroni test was chosen to compare DGGE strips and band numbers among the five groups. An extension *t* test after non-parametric Kruskal-Wallis *H* test was employed to compare the Dice analysis results among multiple groups. The correlation between disease activity and bacterial count was assessed using the Spearman correlation coefficient. SPSS 19.0 software was employed to analyze all the data. Two-tailed tests were used in all analysis and *P* values of ≤ 0.05 were considered statistically significant.

RESULTS
=======

Bacteria in fecal samples from UC patients
------------------------------------------

The demographic details of the study patients are shown in Table [1](#T1){ref-type="table"}. DNA extracts from the fecal samples from different individuals presented variable number of bands after PCR-DGGE analysis. A band representing identical or similar sequences of the V3 regions of the 16S rRNA gene was observed, reflecting the dominant bacterial communities in the fecal samples.

Examination of digital DGGE profiles from healthy controls showed relative stability among different individuals (Figure [1](#F1){ref-type="fig"}). Profiles from UC patients shown in Figure [2](#F2){ref-type="fig"} suggested significant variation in the position and number of bands compared with the healthy controls. The number of bands, which reflected the diverse microbiota, was 17 ± 3 in the 16 healthy controls and 13 ± 3 in the 41 UC patients (*P* = 0.001). Differences were also seen among the subgroups of UC patients (Figure [3](#F3){ref-type="fig"}). These results reveal that the number of predominant microbiota was negatively correlated with the Mayo classification (*r* = -6.591, *P \<* 0.01). The Kruskal-Wallis *H* test showed greater similarity between groups than within the groups, which revealed variation in the predominant microbiota with clinical status (Table [2](#T2){ref-type="table"}). UPGMA tree analysis showed similar results (Figure [4](#F4){ref-type="fig"}). PCA analysis of healthy and UC groups revealed large differences in the predominant species among the control group, remission and mild group, and the moderate and severe group (Figure [5](#F5){ref-type="fig"}).

![Denaturing gradient gel electrophoresis profiles of fecal samples from healthy controls. A: Denaturing gradient gel electrophoresis (DGGE) profiles; B: Marked DGGE profiles. DGGE bands showed relative stability among different individuals.](WJG-22-8929-g001){#F1}

###### 

Dice analysis of healthy control and ulcerative colitis subgroups

  **Group**   **Control**                                        **Remission**                                      **Mild**                                           **Moderate**                                       **Severe**
  ----------- -------------------------------------------------- -------------------------------------------------- -------------------------------------------------- -------------------------------------------------- --------------------------------------------------
  Control     (49.79 ± 11.24)%[a](#T2FN1){ref-type="table-fn"}   (35.32 ± 14.86)%                                   (30.13 ± 11.23)%                                   (31.98 ± 16.48)%                                   (28.18 ± 14.99)%
  Remission                                                      (42.89 ± 18.29)%[a](#T2FN1){ref-type="table-fn"}   (32.79 ± 13.68)%                                   (30.22 ± 15.28)%                                   (26.28 ± 13.94)%
  Mild                                                                                                              (41.83 ± 16.38)%[a](#T2FN1){ref-type="table-fn"}   (29.89 ± 13.10)%                                   (28.31 ± 18.39)%
  Moderate                                                                                                                                                             (43.45 ± 21.32)%[a](#T2FN1){ref-type="table-fn"}   (28.88 ± 13.69)%
  Severe                                                                                                                                                                                                                  (37.12 ± 19.98)%[a](#T2FN1){ref-type="table-fn"}

*P* \< 0.05; result from similarity in the same group *vs* similarity in different groups.

![Denaturing gradient gel electrophoresis profiles showed microbial biodiversity in different ulcerative colitis groups. A: Ulcerative colitis (UC) patients in remission; B: UC patients in the mildly active stage; C: UC patients in the moderately active stage; D: UC patients in the severely active stage.](WJG-22-8929-g002){#F2}

![Number of bands in denaturing gradient gel electrophoresis profiles of samples obtained from 41 ulcerative colitis patients. The number of bands decreased significantly from healthy controls to severe ulcerative colitis.](WJG-22-8929-g003){#F3}

![UPGMA tree analysis of healthy controls and ulcerative colitis patients at different stages. 1-16: Healthy controls; 17-26: Ulcerative colitis (UC) patients in remission; 27-37: UC patients in the mildly active stage; 38-47: UC patients in the moderately active stage; 48-57: UC patients in the severely active stage. UPGMA tree analysis showed a significant difference among groups of healthy controls and UC patients at different stages.](WJG-22-8929-g004){#F4}

![Principal component analysis of denaturing gradient gel electrophoresis microbial profiles in fecal samples of healthy controls and ulcerative colitis patients at different stages. Clustering of similar microbial profiles showed systematic differences among different groups.](WJG-22-8929-g005){#F5}

Sequencing results after purification (based on digital DGGE profiles) showed the presence of a greater number of *C. perfringens* and fewer *Faecalibacterium prausnitzii* (*F. prausnitzii*) and *Eubacterium rectale* (*E. rectal*) in UC group compared with the control group. *C. perfringens* was present predominantly in severe UC.

Bacteria in fecal samples of pouchitis patients
-----------------------------------------------

Significant changes occurred in the position and number of bands from patients with pouchitis when compared with NP and healthy controls (Figure [6](#F6){ref-type="fig"}). Differences in the number of bands in the controls (17 ± 3 bands), NP (11 ± 3 bands) and pouchitis (8 ± 2 bands) are shown in Figure [7](#F7){ref-type="fig"} (ANOVA test). A Bonferroni test showed greater similarity between groups than within groups, suggesting differences in the predominant species in the healthy controls, NP and pouchitis groups (Table [3](#T3){ref-type="table"}). These results suggested that patients with pouchitis had an altered microbiota composition compared with healthy individuals. UPGMA tree analysis showed similar results (Figure [8](#F8){ref-type="fig"}). PCA analysis of healthy control and pouchitis groups revealed great variation in the predominant species in pouchitis compared with non-pouchitis and healthy controls, which also differed from each other (Figure [9](#F9){ref-type="fig"}).

###### 

Dice analysis of healthy control and pouchitis subgroups

  **Group**   **Control**                                        **Pouchitis**                                      **NP**
  ----------- -------------------------------------------------- -------------------------------------------------- --------------------------------------------------
  Control     (49.79 ± 11.24)%[a](#T3FN1){ref-type="table-fn"}   (25.33 ± 11.13)%                                   (28.86 ± 14.23)%
  Pouchitis                                                      (35.43 ± 13.30)%[a](#T3FN1){ref-type="table-fn"}   (20.87 ± 12.31)%
  NP                                                                                                                (35.39 ± 10.80)%[a](#T3FN1){ref-type="table-fn"}

*P* \< 0.05; result from similarity in the same group *vs* similarity in different groups. NP: No pouchitis.

![Denaturing gradient gel electrophoresis profiles of fecal samples from patients with pouchitis. A: Denaturing gradient gel electrophoresis (DGGE) profiles; B: Marked DGGE profiles. DGGE bands revealed the relative stability of the microbiota in pouchitis group.](WJG-22-8929-g006){#F6}

![Number of bands in denaturing gradient gel electrophoresis profiles of samples obtained from patients receiving surgery. The number of bands was reduced significantly in pouchitis compared with the control group and the no pouchitis (NP) group.](WJG-22-8929-g007){#F7}

![UPGMA tree analysis of healthy controls and postoperative patients. 1-16: Healthy controls; 17-27: UC patients without pouchitis after IPAA; 28-35: Patients with pouchitis. UPGMA tree analysis showed a significant difference among the three groups.](WJG-22-8929-g008){#F8}

![Principal component analysis of denaturing gradient gel electrophoresis microbial profiles in fecal samples of healthy controls and patients with pouch (with or without pouchitis). Clustering of similar microbial profiles showed significant differences among the three groups.](WJG-22-8929-g009){#F9}

Sequencing results after purification (based on digital DGGE profiles) showed fewer *E. rectale* and more *C*. *perfringens* in the pouchitis group compared with the NP and control groups.

As shown in Table [4](#T4){ref-type="table"}, the DGGE profiles in pouchitis patients varied significantly from UC in remission to the severe state, while the NP group of patients differed from UC in remission. The results showed that patients with a pouch have an altered microbiota diversity compared with UC patients (Figure [10](#F10){ref-type="fig"}). The diversity of the microbiota from pouchitis patients was lower than that in severe UC patients. A normal pouch can be can be present along with mild, moderate and severe UC. The sequencing results for the UC and pouchitis groups showed that they shared a similar microbiota, such as *C. perfringens*.

###### 

Bacterial diversity comparison

                        **Healthy controls**                    **UC**                                  **Pouch**                                                                                                                                                       
  --------------------- --------------------------------------- --------------------------------------- --------------------------------------- --------------------------------------- --------------------------------------- --------------------------------------- ---------------------------------------
  Healthy controls      \-                                      0.298                                   0.006[a](#T4FN1){ref-type="table-fn"}   0.001[a](#T4FN1){ref-type="table-fn"}   0.000[a](#T4FN1){ref-type="table-fn"}   0.000[a](#T4FN1){ref-type="table-fn"}   0.000[a](#T4FN1){ref-type="table-fn"}
  Remission UC          0.298                                   \-                                      0.113                                   0.020[a](#T4FN1){ref-type="table-fn"}   0.000[a](#T4FN1){ref-type="table-fn"}   0.014[a](#T4FN1){ref-type="table-fn"}   0.003[a](#T4FN1){ref-type="table-fn"}
  Mild UC               0.006[a](#T4FN1){ref-type="table-fn"}   0.113                                   \-                                      0.404                                   0.019[a](#T4FN1){ref-type="table-fn"}   0.007[a](#T4FN1){ref-type="table-fn"}   0.125
  Moderate UC           0.001[a](#T4FN1){ref-type="table-fn"}   0.020[a](#T4FN1){ref-type="table-fn"}   0.404                                   \-                                      0.128                                   0.009[a](#T4FN1){ref-type="table-fn"}   0.448
  Severe UC             0.000[a](#T4FN1){ref-type="table-fn"}   0.000[a](#T4FN1){ref-type="table-fn"}   0.019[a](#T4FN1){ref-type="table-fn"}   0.128                                   \-                                      0.019[a](#T4FN1){ref-type="table-fn"}   0.496
  NP: PDAI \< 7         0.000[a](#T4FN1){ref-type="table-fn"}   0.014[a](#T4FN1){ref-type="table-fn"}   0.007[a](#T4FN1){ref-type="table-fn"}   0.009[a](#T4FN1){ref-type="table-fn"}   0.019[a](#T4FN1){ref-type="table-fn"}   \-                                      0.034[a](#T4FN1){ref-type="table-fn"}
  Pouchitis: PDAI ≥ 7   0.000[a](#T4FN1){ref-type="table-fn"}   0.003[a](#T4FN1){ref-type="table-fn"}   0.005[a](#T4FN1){ref-type="table-fn"}   0.448                                   0.496                                   0.034[a](#T4FN1){ref-type="table-fn"}   \-

*P* \< 0.05. NP: No pouchitis; UC: Ulcerative colitis; Pouch: Ileal pouch established during ileal pouch-anal anastomosis surgery; pouchitis: Inflammation of ileal pouch; PDAI: Pouchitis Disease Activity Index.

![Number of bands in denaturing gradient gel electrophoresis profiles of samples obtained from all subjects. The number of bands was reduced significantly in pouch group (UC patients who underwent IPAA, with or without pouchitis) compared with the control group and the UC group. UC: Ulcerative colitis.](WJG-22-8929-g010){#F10}

DISCUSSION
==========

In this study, we focused on UC patients after IPAA surgery, and specifically compared patients developing pouch inflammation with those without surgery. Our digital analysis of stool samples showed that the predominant microbiota in UC patients was reduced compared with the healthy group. Sequence analysis showed more *C. perfringens* and less *F. prausnitzii* and *E. rectale* in the UC group. Levels of *E. rectale* (a butyrate-producing bacteria) were significantly reduced on UC mucosa\[[@B17]\], and had high age dependence. High clinical activity indices, as well as sigmoidoscopy scores, were associated with *E. rectale*\[[@B18]\]. Vermeiren demonstrated fewer *E. rectale* shown in UC patients *via* a dynamic gut model of the mucin environment\[[@B17]\]. *C. perfringens*, a Gram-positive, anaerobic, spore-forming bacillus, is found in the intestinal contents of both animals and humans\[[@B19]\]. *C. perfringens* is an intestinal commensal organism as well as a pathogen, for example, *via* production of toxins that damage the host tissues\[[@B20]\]. *C. perfringens* exerts proteolytic and mucinase activity, both of which could mediate the pathogenesis of inflammatory bowel disease (IBD)\[[@B21]\]. *C. perfringens* found in IBD patients, which is thought to be an important factor during the immunopathogenesis of IBD, could result from dysbiosis\[[@B22]\]. Falk showed that there were more *C. perfringens* in pouchitis patients\[[@B24]\]. Another study found that 21% of the total bacteria in colonic specimens collected from patients with UC belonged to clostridia of clusters I, II and XI, which were not found in the control groups\[[@B23]\]. We should keep in mind that ileum tissues of UC patients were the origin of the present pouches. *F. prausnitzii* is the most host species-specific microbe in the study of IBD. Sokol et al\[[@B25]\] studied a small group of 17 UC patients and reported a reduction in *F. prausnitzii* in active UC patients. A strong anti-inflammatory effect of *F. prausnitzii* has been demonstrated both *in vitro* and *in vivo*\[[@B26]\]. Machiels et al\[[@B27]\] observed a significant inverse correlation between disease activity and numbers of *F. prausnitzii*, indicating that a deficiency of this species provokes or enhance inflammation. *F. prausnitzii* produces high concentrations of butyrate, a vital energy source for colonocytes, which also prevents mucosal atrophy. Consequently, butyrate improves the mucosal barrier function of the colon. Furthermore, butyrate exhibits immunomodulatory and anti-inflammatory effects by downregulating pro-inflammatory cytokines\[[@B28]\]. Our data showed that bacterial biodiversity in feces decreased distinctly with the severity of Mayo classification compared with healthy controls. Studies have demonstrated that the mucosal biopsies from patients with active Crohn's disease (CD) or active UC showed reduced bacterial diversity after analysis of 16S rRNA genes\[[@B29]\]. Furthermore, Manichanh et al\[[@B30]\] reported a reduction in the phylum Firmicutes in CD in remission using an extensive metagenomic analysis. Consistent with previous studies, our results confirmed that bacterial diversity was reduced in fecal samples from UC patients at different grades, and demonstrated changes in the microbial composition among subgroups in UC. The decreased biodiversity in UC might disrupt the stability of gut ecosystem. The results revealed that changes in the predominant bacteria were consistent with the Mayo classification. Therefore, we suggest that the fecal microflora in UC patients is reduced in aggravated intestinal lesions. A previous study by Wills et al\[[@B31]\] reported patient-specific shifts in microbial composition in UC patients showing altered pathological activity over time. The changes were more pronounced in CD cases than in UC patients, suggesting their role in the inflammatory process of UC.

By contrast, the number of bands on the DGGE profiles from pouchitis patients varied between UC and healthy controls. We showed a decrease in bacterial diversity and reduced abundance of predominant bacteria in UC pouches. *R. gnavus* infection, especially occurring as the predominant microbiota before colectomy, was shown to increase the risk of pouchitis 1 year after IPAA\[[@B12]\]. *R. gnavus* produces the bacteriocin ruminococcin A, which inhibits the growth of phylogenetically-related species and various bifidobacterial and clostridial species\[[@B32]\]. Ruminococcin A also degrades intestinal mucin\[[@B33]\] and induced α-galactosidase and β-glucuronidase activity *in vitro*\[[@B34]\]. β-glucuronidase activity generates toxic metabolites in the colon, which provoke local inflammation. Png et al\[[@B35]\] observed an increase in mucolytic bacteria, including *R. gnavus*, in biopsies of patients with UC and CD. Our data are supported by reports from several groups that analyzed fecal or biopsy samples using different DNA-based methods\[[@B7]\], further confirming the association between changes in microbiota and pouchitis. By contrast, the variability in endogenous factors, including secretion of mucins, defensins, cytokines and immunoglobulins, might also affect the composition of predominant bacterial species in UC and pouchitis. However, data about the effects of these secretions effects on the variability of UC is limited. Studies involving UC have revealed that a high percentage of fecal bacteria (about 30%-40% of dominant species) belong to unusual genera in healthy populations\[[@B36]\]. Hypothetically, the decreased number of stable commensals in individuals that are genetically susceptible to pouchitis would break this first line of natural defense against potentially invasive bacteria, resulting in inflammation.

In conclusion, our research demonstrated reduced biodiversity of fecal microbiota in UC and pouchitis patients. There were fewer *F. prausnitzii* and *E. rectale* in UC, more *R. gnavus* in pouchitis and more *C. perfringens* in both UC and pouchitis.

COMMENTS
========

Background
----------

Pouchitis is a commonly-seen complication in patients with ulcerative colitis (UC) following ileal pouch-anal anastomosis (IPAA) procedure. The gut microbiome is considered to play a vital role in the occurrence and development of UC. In addition, antibiotics and probiotics have already been used to treat and prevent pouchitis. However, direct evidence of dysbacteriosis in pouchitis is lacking.

Research frontiers
------------------

Gut microbiota is hot topic in field of intestinal inflammation, especially in inflammatory bowel disease (IBD), where data are often conflicting.

Innovations and breakthroughs
-----------------------------

The authors demonstrated the role of the reduced diversity and the changed composition of intestinal microbiota in the pathogenesis of pouchitis. Reduced levels of *Faecalibacterium prausnitzii* and *Eubacterium rectal* were confirmed in UC patients, and *Clostridium perfringens* was significantly increased in UC and pouchitis.

Applications
------------

These findings provide new clues to better understand the pathogenesis of pouchitis in UC patients subjected to IPAA, although the findings will not be used immediately in the treatment of pouchitis.

Terminology
-----------

**Pouchitis:** An inflammation in the intestinal pouch, which is established following the proctocolectomy IPAA procedure for patients with UC to prevent permanent abdominal fistula. Pouchitis could have serious consequences, such as bloody diarrhea and even ileal pouch failure.

Peer-review
-----------

The manuscript definitely deals with a hot topic in the IBD and intestinal inflammation field, where data are often conflicting. The deep insight and detailed description made by the authors of the diversity of microbiota in healthy people and patients will provide new clues to better understand the pathogenesis of pouchitis following IPAA for UC.
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